Catalyst Crew Technologies Corp. (OTC: CCTC) announced the establishment of LataMed AI VE, C.A., a Venezuelan operating subsidiary intended to support the company's telehealth regulatory, commercialization, and healthcare deployment initiatives in Venezuela. The subsidiary will serve as a localized operating entity for the phased deployment of the company's telehealth platform and broader healthcare delivery infrastructure.
Management anticipates that operational activities through LataMed AI VE, C.A. may commence in the coming weeks, subject to regulatory progression, operational readiness, and commercialization planning. The subsidiary is expected to work alongside the company's existing framework, including Inversiones Long 33, C.A., as part of a broader regional infrastructure strategy designed to strengthen local regulatory flexibility, healthcare service operations, permit management, and long-term commercialization scalability.
The establishment of LataMed AI VE, C.A. may significantly enhance the company's ability to manage localized healthcare operations, support phased commercialization initiatives, improve operational deployment readiness, and facilitate telehealth platform expansion across Venezuela and other targeted Latin American markets. The subsidiary is expected to support patient onboarding systems, provider coordination capabilities, telehealth infrastructure deployment, regulatory compliance procedures, commercialization planning, healthcare analytics integration, and broader operational management as part of the company's evolving Latin American healthcare ecosystem.
Catalyst Crew continues to advance telehealth platform development, pilot deployment readiness, regulatory progression, healthcare analytics integration, and commercialization initiatives through its digital healthcare ecosystem, including active platform development and testing through its telehealth interface at https://latamedai.org. The company is also coordinating regulatory initiatives with applicable healthcare authorities, including the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloría Sanitaria (SACS).
Dr. Kevin Rodan Levy, Chief Executive Officer of Catalyst Crew Technologies Corp., stated: "The establishment of LataMed AI VE, C.A. represents an important operational milestone as we continue strengthening our localized healthcare infrastructure in Venezuela. We believe this new subsidiary will play a key role in supporting regulatory progression, commercialization readiness, and phased telehealth deployment as we move toward broader operational execution."
For leaders in business and technology, this move signals Catalyst Crew's commitment to building scalable digital health solutions in emerging markets, where access to modernized healthcare delivery systems is in high demand. The subsidiary's focus on regulatory compliance and local operations could streamline the company's path to commercialization, potentially impacting healthcare access in Venezuela and similar regions. Investors and industry observers should monitor the company's progress as it navigates regulatory hurdles and seeks to deploy its AI-driven telehealth platform.
